Cart
sales@molnova.com
Goxalapladib
CAS No. 412950-27-7
Goxalapladib( —— )
Catalog No. M35993 CAS No. 412950-27-7
Goxalapladib（GSK 677116） is a small molecule compound that can be used to treat cardiovascular risks associated with atherosclerosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 276 | In Stock |
|
| 10MG | 394 | In Stock |
|
| 25MG | 616 | In Stock |
|
| 50MG | 830 | In Stock |
|
| 100MG | 1097 | In Stock |
|
| 200MG | 1507 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGoxalapladib
-
NoteResearch use only, not for human use.
-
Brief DescriptionGoxalapladib（GSK 677116） is a small molecule compound that can be used to treat cardiovascular risks associated with atherosclerosis.
-
DescriptionGoxalapladib（GSK 677116） is a small molecule compound that can be used to treat cardiovascular risks associated with atherosclerosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number412950-27-7
-
Formula Weight718.75
-
Molecular FormulaC40H39F5N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C(N(CC1=CC=C(C=C1)C2=CC=C(C(F)(F)F)C=C2)C3CCN(CCOC)CC3)=O)N4C=5C(C(=O)C=C4CCC6=C(F)C(F)=CC=C6)=CC=CN5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
4-Methylcatechol
4-methylcatechol is a metabolite of homoprotocatechuic acid. It is both a substrate and a suicide inhibitor of Catechol 23-dioxygenase. 4-methylcatechol is known to induce the production of brain-derived neurotrophic factor (BDNF). Recent studies have suggested that a lack of brain-derived neurotrophic factor (BDNF) in the limbic system may cause neuropathic pain.
-
Catch-Relaxing Pepti...
Catch-Relaxing Peptide (CARP)
-
Activated Protein C ...
The peptide region containing residues 390-404 in Activated Protein C (APC) is essential for anticoagulant activity and is available for interaction with antibodies or with other proteins, such as the macromolecular substrates Factors Va or VIIIa. APC regulates blood coagulation by proteolytic inactivation of the blood coagulation cofactors Va and VIIIa.
